United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results
暂无分享,去创建一个
[1] B. Rabinowitz,et al. [Aspirin in coronary heart disease]. , 1989, Harefuah.
[2] R. Heyningen,et al. DO ASPIRIN-LIKE ANALGESICS PROTECT AGAINST CATARACT? A Case-control Study , 1986, The Lancet.
[3] G. Davı̀,et al. Clinical pharmacology of platelet cyclooxygenase inhibition. , 1985, Circulation.
[4] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[5] R. Rosati,et al. Risk of ischemic heart disease in patients with TIA , 1984, Neurology.
[6] C. Garrard,et al. The effect of aspirin on lung mucociliary clearance. , 1983, The New England journal of medicine.
[7] W. O'Fallon,et al. Reversible is chemic neurologic deficit (RIND) in a community , 1982, Neurology.
[8] W. O'Fallon,et al. Reversible ischemic neurologic deficit (RIND) in a community: Rochester, Minnesota, 1955-1974. , 1982, Neurology.
[9] P. Glasziou. Aspirin after Myocardial Infarction , 1980, The Lancet.
[10] A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. , 1980, JAMA.
[11] J. Mann,et al. ASPIRIN PROPHYLAXIS IN MIGRAINE , 1978, The Lancet.